SCHEMBL1629555

SCHEMBL1629555

COc1cc(OC)c(-c2ccnn2-c2ccccc2)cc1I

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE10A Q9Y233 7/20 0.48
▸ MAPT P10636 4/20 0.41
▸ ALDH1A1 P00352 3/20 0.41
▸ MDM2 Q00987 1/20 0.40
▸ HSP90AA1 P07900 2/20 0.40
▸ HPGDS O60760 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ LMNA P02545 1/20 0.38
▸ ATM Q13315 1/20 0.38
▸ PTGER1 P34995 1/20 0.38
▸ POLB P06746 1/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ ALK Q9UM73 1/20 0.37
▸ MAPK1 P28482 1/20 0.36
▸ ESR2 Q92731 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1628962 0.87 MAPK14 (0.42) PDE10AMAPTALDH1A1LMNAATM
SCHEMBL12722869 0.85 PDE10A (0.49) PDE10AMAPTALDH1A1MDM2HSP90AA1
SCHEMBL1631549 0.84 NPBWR1 (0.41) PDE10AMAPTALDH1A1HSP90AA1PTGER1
SCHEMBL27675424 0.83 PTGER1 (0.39) PDE10AMAPTALDH1A1HSP90AA1LMNA
SCHEMBL1219068 0.83 HSP90AA1 (0.45) PDE10AMAPTALDH1A1HSP90AA1LMNA
SCHEMBL1629564 0.82 HSP90AA1 (0.44) PDE10AMAPTALDH1A1HSP90AA1ATM
SCHEMBL1631531 0.82 HSP90AA1 (0.62) PDE10AMAPTHSP90AA1ALK
SCHEMBL1629833 0.82 POLB (0.40) MAPTPOLBMEN1KMT2A
SCHEMBL1630525 0.81 HSP90AA1 (0.44) PDE10AALDH1A1HSP90AA1LMNAMEN1
SCHEMBL12722811 0.81 PDE10A (0.48) PDE10AMAPTALDH1A1HSP90AA1HPGDS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932401-B2 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant MERCK PATENT GMBH (DE) 2011-04-26 — — US disclosed
US-7932401-B2 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant MERCK PATENT GMBH (DE) 2011-04-26 — — US disclosed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 — — US disclosed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 — — US disclosed
CN-101006061-A 1,5-diphenylpyrazoles MERCK PATENT GMBH (DE) 2007-07-25 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085904-A1 1,5-Diphenylpyrazoles HSP90AB1, HSP90AA1, HSP90AB2P PDE10A 3756/4885MAPT 2299/4885ALDH1A1 777/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback